Correction: Th1 high  in tumor microenvironment is an indicator of poor prognosis for patients with NSCLC

Huang Jian; Shen Fangrong; Huang Haitao; Ling Chunhua; Zhang Guangbo

doi:10.18632/oncotarget.18440

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Corrections:

Correction: Th1^high in tumor microenvironment is an indicator of poor prognosis for patients with NSCLC

Huang Jian, Shen Fangrong, Huang Haitao, Ling Chunhua and Zhang Guangbo _

PDF | How to cite

Oncotarget. 2017; 8:39936-39936. https://doi.org/10.18632/oncotarget.18440

Metrics: PDF 1562 views | ?

Present: Author contributions were not correctly attributed.

Correct: The proper author contributions are shown below.

Huang Jian and Shen Fangrong have contributed to this work and are co-first authors.

Original article: Oncotarget. 2017; 8:13116-25. DOI:10.18632/oncotarget.14471.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 18440

Publication Alerts

Corrections:

Correction: Th1high in tumor microenvironment is an indicator of poor prognosis for patients with NSCLC

Correction: Th1^high in tumor microenvironment is an indicator of poor prognosis for patients with NSCLC